Sandu Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 17.22 | 18.77 | 17.67 |
| Operating Expense | 16.28 | 17.72 | 16.76 |
| Net Profit | 0.04 | 0.98 | 0.52 |
| Net Profit Margin | 0.23% | 5.22% | 2.94% |
| Earning Per Share | 0.04 | 1.01 | 0.54 |
| EBIDTA | 0.77 | 1.13 | 0.92 |
| Effective Tax Rate | 57.45% | -4.76% | 21.98% |
Particulars
Mar 2026
Revenue17.22
Operating Expense16.28
Net Profit0.04
Net Profit Margin0.23
Earning Per Share0.04
EBIDTA0.77
Effective Tax Rate57.45
